ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 63 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -23.1% | 7,403 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -18.8% | 7,403 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $16,000 | -38.5% | 7,403 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | -64.4% | 7,403 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $73,000 | -8.8% | 7,403 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $80,000 | +5.3% | 7,403 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $76,000 | -43.7% | 7,403 | +14.8% | 0.00% | -50.0% |
| Q2 2020 | $135,000 | +150.0% | 6,451 | +17.1% | 0.01% | +100.0% |
| Q1 2020 | $54,000 | +5.9% | 5,510 | +25.3% | 0.00% | +50.0% |
| Q4 2019 | $51,000 | +112.5% | 4,398 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $24,000 | -53.8% | 4,398 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $52,000 | +126.1% | 4,398 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $23,000 | +64.3% | 4,398 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $14,000 | -48.1% | 4,398 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $27,000 | +17.4% | 4,398 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $23,000 | +475.0% | 4,398 | +191.5% | 0.00% | – |
| Q1 2017 | $4,000 | – | 1,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |